New app aims to empower cancer survivors with disabilities
NCT ID NCT06185738
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a mobile app called WeCanManage designed to help cancer survivors with disabilities manage long-term effects of their illness and treatment. Twenty adults who had breast cancer, head and neck cancer, or sarcoma used the app and reported on how helpful and easy it was to use. The goal was to see if the app could improve their confidence and quality of life.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
20 people
The number who actually took part.
- Started
-
Jul 2024
- Finished
-
Aug 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Usability Testing of the WeCanManage High Fidelity Prototype * Age 18 or older * Diagnosis of breast cancer, head and neck cancer or sarcoma * Completion of active treatment * Self-identify as a person with a disability according to the Americans with Disabilities .Act and the American Community Survey 6-disability questions * Able to understand and communicate in English * Medically stable enough to participate in two data collection sessions totaling 2 hours Evaluation of the WeCanManage App * Age 18 or older * Diagnosis of breast cancer, head and neck cancer or sarcoma * Completion of primary (i.e. surgery, chemotherapy, and/or radiation); may still be under-going endocrine or hormone therapies * Self-identify as experiencing disabling after-effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Able to read, understand and communicate in English * Ownership of a smartphone, tablet, or personal computer. * Internet access Exclusion Criteria: Usability Testing of the WeCanManage High Fidelity Prototype * No diagnosis of breast cancer, head and neck cancer or sarcoma * In active treatment * Does not self-identify as a person with a disability according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Not able to understand and communicate in English * Not medically stable enough to participate in two data collection sessions totaling 2 hours Evaluation of the WeCanManage App * Age 17 or younger * No diagnosis of breast cancer, head and neck cancer or sarcoma * In active treatment * Does not self-identify as experiencing long-term effects of cancer and its treatment according to the Americans with Disabilities Act and the American Community Survey 6-disability questions * Not able to read, understand, and communicate in English * Does not have access to internet enabled smartphone, tablet, or personal computer * Does not have access to the internet
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Illinois
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Experimental pill HG146 put to the test against rare head and neck cancer
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?